FDA plans to conduct an internal audit of its new 510(k) refuse-to-accept program this June.
The 15-day quick-review program involves the use of a checklist by FDA reviewers to see if a 510(k) submission contains all of the required documentation and is
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?